Affinity Technologies, Inc. (NASDAQ:BIAF) released its financial results for the year ended December 31, 2025, according to a statement issued Friday. The biotechnology company reported revenue of $6.

The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

The Forkhead box A (FOXA) transcription factors are pioneer factors that orchestrate diverse cellular and developmental processes. Within the respiratory system, FOXA1, FOXA2, and FOXA3 have emerged ...

aFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada bFaculty of Land and Food Systems, University of British Columbia, Vancouver, BC, Canada cDivision of ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

This study investigates the synergistic effects of melatonin and glucocorticoids in the management of asthma and allergic airway inflammation. While glucocorticoids are the cornerstone of asthma ...

Abstract: Synthetic data generation emerges as a strategy to mitigate data scarcity in digital pathology, where complicated tissue and cellular features are correlated with cancer diagnosis. The ...

SPOKANE, Wash. -- The Spokane Allergy & Asthma Clinic suddenly shut down its practice on Wednesday. In a post on Facebook, the clinic did not provide a reason for the closure. The clinic said it would ...

SPOKANE, Wash. — The abrupt closure of Spokane Allergy and Asthma Clinic has left patients shocked and scrambling to find alternative care after the facility shut down unexpectedly on February 18th.

Spokane Allergy & Asthma Clinic abruptly announced its immediate closure on Wednesday, stunning patients who relied on the specialty clinic for allergy shots and other medications. “It is with heavy ...